CN Patent
CN104379148A — 用于治疗神经障碍的雌激素组分
Assigned to Newlaris Ag · Expires 2015-02-25 · 11y expired
What this patent protects
本发明涉及某些雌激素组分例如雌四醇在神经障碍例如新生儿低氧-缺血性脑病(HIE)中的预防和治疗应用。
USPTO Abstract
本发明涉及某些雌激素组分例如雌四醇在神经障碍例如新生儿低氧-缺血性脑病(HIE)中的预防和治疗应用。
Drugs covered by this patent
- Slynd (DROSPIRENONE) · Exeltis Usa Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.